Mast cell mediators
- Effect of mast cell mediators on sleep
- Histamine: Intended functions and mast cell symptoms
- Leptin: the obesity hormone released by mast cells
- Lesser known mast cell mediators (Part 1)
- Lesser known mast cell mediators (Part 2)
- Lesser known mast cell mediators (Part 3)
- Lesser known mast cell mediators (Part 4)
- Lesser known mast cell mediators (Part 5)
- Lesser known mast cell mediators (Part 6)
- Mast cell mediator release mechanisms
- Mast cell mediators: Prostaglandin D2 (PGD2)
- Mast cell mediators: Recommended testing for MCAS diagnosis
- Mast cell mediators: Sphingosine-1-phosphate
- Mast cells and cardiac and vascular dysfunction
- Mast cells, heparin and bradykinin: The effects of mast cells on the kinin-kallikrein system
- Mast cells in vascular disease: Part 1
- Mast cells in vascular disease: Part 2
- Mast cells in vascular disease: Part 3
- Master table of de novo mast cell mediators
- Master table of stored mast cell mediators
- MCAS: Neurologic and psychiatric symptoms
- Prostaglandin E2, mast cells and asthma
- Prostaglandins and leukotrienes
- Symptoms, mediators and mechanisms: A general review (Part 1 of 2)
- Symptoms, mediators and mechanisms: A general review (Part 2 of 2)
Bradykinin
- Chronic urticaria and angioedema: Part 3
- Chronic urticaria and angioedema: Part 4
- Mast cells, heparin and bradykinin: The effects of mast cells on the kinin-kallikrein system
Histamine
- Anti-inflammatory properties of H1 antihistamines
- Histamine effects on neurotransmitters (serotonin, dopamine and norepinephrine)
- Histamine: Intended functions and mast cell symptoms
- Mast cell medications: Antihistamines by receptor activity
- Mast cells and cardiac and vascular dysfunction
- Pharmacology of H1 antihistamines
Prostaglandin D2
- Exercise and mast cell activity
- Mast cell mediators: Prostaglandin D2 (PGD2)
- MCAS: Neurologic and psychiatric symptoms
Platelet Activating Factor
Tryptase
- Patient questions: Everything you wanted to know about tryptase?
- Patient questions: Why isn’t tryptase used to track SM progression in patients with SM-AHNMD?